Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith M Regan

Showing results (31-40 of 259) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to L. MoscettiMarco Colleoni, Kathryn P Gray, Richard D Gelber, et al.
The Oncologist|April 5, 2022
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" SurrogacyMarc Buyse, Everardo D Saad, Tomasz Burzykowski, et al.
The American Journal of Clinical Nutrition|March 28, 2002
Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance techniqueSudhir Borgonha, Meredith M Regan, Seung-Ho Oh, et al.
The American Journal of Clinical Nutrition|June 24, 2004
Daily requirement for total sulfur amino acids of chronically undernourished Indian menAnura V Kurpad, Meredith M Regan, Sureka Varalakshmi, et al.
Journal of the American College of Surgeons|February 21, 2009
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancerMonika K Krzyzanowska, Meredith M Regan, Mark Powell, et al.
Breast Cancer Research : BCR|June 4, 2011
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancerMeredith M Regan, Karen N Price, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Physicians' experiences with BRCA1/2 testing in community settingsNancy L Keating, Kathryn A Stoeckert, Meredith M Regan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 7, 2017
Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et alKarin Ribi, Alan Coates, Lynette Blacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Reply to F. Tomao et alKarin Ribi, Jürg Bernhard, Weixiu Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2024
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK TrialDavid J Einstein, Meredith M Regan, Julia S Stevens, et al.
Pageof 26

Showing results (31-40 of 259) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to L. MoscettiMarco Colleoni, Kathryn P Gray, Richard D Gelber, et al.
The Oncologist|April 5, 2022
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" SurrogacyMarc Buyse, Everardo D Saad, Tomasz Burzykowski, et al.
The American Journal of Clinical Nutrition|March 28, 2002
Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance techniqueSudhir Borgonha, Meredith M Regan, Seung-Ho Oh, et al.
The American Journal of Clinical Nutrition|June 24, 2004
Daily requirement for total sulfur amino acids of chronically undernourished Indian menAnura V Kurpad, Meredith M Regan, Sureka Varalakshmi, et al.
Journal of the American College of Surgeons|February 21, 2009
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancerMonika K Krzyzanowska, Meredith M Regan, Mark Powell, et al.
Breast Cancer Research : BCR|June 4, 2011
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancerMeredith M Regan, Karen N Price, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Physicians' experiences with BRCA1/2 testing in community settingsNancy L Keating, Kathryn A Stoeckert, Meredith M Regan, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 7, 2017
Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et alKarin Ribi, Alan Coates, Lynette Blacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Reply to F. Tomao et alKarin Ribi, Jürg Bernhard, Weixiu Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2024
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK TrialDavid J Einstein, Meredith M Regan, Julia S Stevens, et al.
Pageof 26